Is semaglutide at 8 mg/mL stable enough for three weeks of multi-withdrawal use?

Asked 14 Jun 2024Modified 2.1 years agoViewed 54k times

Conditions: semaglutide · 8 mg/mL · three weeks.

I want to know whether there is evidence behind this or only repetition.

I have checked the obvious registries and monographs without success.

Has anyone verified this independently?

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questionsbacteriostatic-water

bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questionsshelf-life

shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

327 questionssemaglutide

semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions

shareeditfollowflag

askedravenna_pace14k3814 Jun 2024

No answers yet

This question has not been answered. It has been viewed 54k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.

Linked questions

11 What fraction of loss on semaglutide is lean mass according to STEP 3?23 How does reference-standard error propagate into a semaglutide content figure?18 Is SURMOUNT-5 a fair head-to-head comparison?34 How comparable are orforglipron and mazdutide on the evidence available?

Janoshik Analytical

Independent HPLC, identity and content testing. Chromatograms included with every report.

Submit a sample

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP, batch documentation included.

Visit GL Biochem

Hot on the stack

My orforglipron vial sat at 40 °C for ten days — is testing worth it before use?29 votes · 5 answers · 46k views Does early satiety at week two of survodutide usually resolve without a dose change?37 votes · 5 answers · 47k views Why did my ApoB move after sixteen weeks on oral semaglutide?33 votes · 5 answers · 48k views Is 5 mg weekly a defensible maintenance dose for ecnoglutide?37 votes · 5 answers · 48k views Is there any published stability data for orforglipron at 40 °C?33 votes · 5 answers · 44k views Is 2.5 mg/mL a sensible working concentration for liraglutide, or should I go lower?20 votes · 4 answers · 44k views How many units on a 1 mL luer-lock syringe is a 5 mg dose at 8 mg/mL?17 votes · 5 answers · 45k views

The stack

Questions5.2k

Answers20k

Accepted3.1k

Unanswered739

Tags107

Users220

Vendors tracked20